ALETA-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ALETA-001, covering 2025-07-28 to 2025-07-28. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies [Phase 1, Phase 2]